O emprego de hormônio luteinizante recombinante associado ao hormônio folículo-estimulante recombinante nos protocolos de estimulação ovariana com antagonista do GnRH

Página do item simplificado
dc.contributor.authorBaruffi, Ricardo L.R.
dc.contributor.authorMauri, Ana L. [UNESP]
dc.contributor.authorPetersen, Cláudia G. [UNESP]
dc.contributor.authorFelipe, Valéria
dc.contributor.authorMartins, Anice M.C. [UNESP]
dc.contributor.authorCornicelli, João
dc.contributor.authorCavagna, Mario
dc.contributor.authorOliveira, João B.A.
dc.contributor.authorFranco Junior, Jose Gonçalves [UNESP]
dc.contributor.institutionCentro de Reprodução Humana Prof. Franco Junior
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.contributor.institutionUniversidade de Santo Amaro
dc.contributor.institutionCentro de Reprodução Humana Prof. Franco Junior, Ribeirão Preto
dc.date.accessioned2014-05-27T11:22:00Z
dc.date.available2014-05-27T11:22:00Z
dc.date.issued2006-10-01
dc.description.abstractThe purpose of this investigation was to verify the efficacy of recombinant LH supplementation for controlled ovarian stimulation in GnRH-antagonist protocol for assisted reproductive technologies cycles. Search strategies included on-line surveys of databases from 1990 to 2006. In this review and meta-analysis, the observed advantages for the LH supplementation protocol were a higher serum estradiol levels on the day of hCG administration and a higher number of mature oocytes. However, there were no differences observed in the total amount of r-FSH administered, days of stimulation, number of oocyte retrieved, the clinical pregnancy rate per oocyte retrieval, the implantation rate and miscarriage rate. This result demonstrates that the association of r-LH with r-FSH may prevent any decrease in estradiol after antagonist administration and a significant higher number of mature oocytes was obtained. Nevertheless, additional randomized controlled trials are needed confirm these observations.en
dc.description.affiliationCentro de Reprodução Humana Prof. Franco Junior, Ribeirão Preto, SP
dc.description.affiliationDepartamento de Ginecologia e Obstetrícia Faculdade de Medicin de Botucatu UNESP, Botucatu, SP
dc.description.affiliationFaculdade de Medicina Universidade de Santo Amaro, São Paulo, SP
dc.description.affiliationCentro de Reprodução Humana Prof. Franco Junior, Ribeirão Preto, Av. Prof. João Fiusa, 689, CEP 14025-310 Ribeirao Preto - SP
dc.description.affiliationUnespDepartamento de Ginecologia e Obstetrícia Faculdade de Medicin de Botucatu UNESP, Botucatu, SP
dc.format.extent9-16
dc.identifierhttps://www.academia.edu/3490307/ICSI-gestational_Carrier_Association_as_a_Strategy_for_Treatment_of_Mayer-_Rokitansky-Kuster-Hauser_Syndrome_Patients_Case_Report_and_Literature_Review
dc.identifier.citationJornal Brasileiro de Reproducao Assistida, v. 10, n. 4, p. 9-16, 2006.
dc.identifier.issn1517-5693
dc.identifier.issn1518-0557
dc.identifier.scopus2-s2.0-33847306557
dc.identifier.urihttp://hdl.handle.net/11449/69156
dc.language.isopor
dc.relation.ispartofJornal Brasileiro de Reproducao Assistida
dc.relation.ispartofsjr0,282
dc.rights.accessRightsAcesso aberto
dc.sourceScopus
dc.subjectGnRH antagonist
dc.subjectOvarian stimulation
dc.subjectRecombinant FSH
dc.subjectRecombinant LH
dc.subjectcetrorelix
dc.subjectchorionic gonadotropin
dc.subjectestradiol
dc.subjectethinylestradiol
dc.subjectethinylestradiol plus gestodene
dc.subjectgonadorelin antagonist
dc.subjectlevonorgestrel
dc.subjectoral contraceptive agent
dc.subjectrecombinant follitropin
dc.subjectrecombinant luteinizing hormone
dc.subjectclinical trial
dc.subjectcombination chemotherapy
dc.subjectdata base
dc.subjectdrug dose regimen
dc.subjectdrug efficacy
dc.subjectdrug mechanism
dc.subjectestradiol blood level
dc.subjecthormone substitution
dc.subjecthuman
dc.subjectlow drug dose
dc.subjectmeta analysis
dc.subjectmonotherapy
dc.subjectoocyte
dc.subjectovary function
dc.subjectpregnancy rate
dc.subjectspontaneous abortion
dc.subjectsystematic review
dc.titleO emprego de hormônio luteinizante recombinante associado ao hormônio folículo-estimulante recombinante nos protocolos de estimulação ovariana com antagonista do GnRHpt
dc.title.alternativeThe use of recombinant luteinizing hormone in addition to recombinant follicle-stimulating hormone in ovarian stimulation with the GnRH-antagonist protocolen
dc.typeArtigo
unesp.campusUniversidade Estadual Paulista (Unesp), Faculdade de Medicina, Botucatupt

Arquivos

Coleções

Artigos - Ginecologia e Obstetrícia - FMB